| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 82.6K | Jun 6, 2024 | Direct | ||
| Kyverna Therapeutics, Inc. | Chief Technology Officer | Common Stock | 22.6K | Apr 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | Apr 11, 2025 | 2 | $0 | 4 | Apr 15, 2025 | Chief Technology Officer |
| KYTX | Kyverna Therapeutics, Inc. | Jun 6, 2024 | 2 | $42.6K | 4 | Jun 10, 2024 | Chief Technology Officer |
| KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Chief Technology Officer |